Skip to main content
Article
Bortezomib and fenretinide induce synergistic cytotoxicity in mantle cell lymphoma through apoptosis, cell-cycle dysregulation, and IκBα kinase downregulation.
Anti-Cancer Drugs (2015)
  • Andrew J. Cowan, Fred Hutchinson Cancer Research Center
  • Shani L. Frayo, Fred Hutchinson Cancer Research Center
  • Oliver W. Press, University of Washington
  • Maria C. Palanca-Wessels, Seattle Genetics
  • John M. Pagel, Fred Hutchinson Cancer Research Center
  • Damian J. Green, University of Washington
  • Ajay K. Gopal, Fred Hutchinson Cancer Research Center
Publication Date
January 10, 2015
DOI
10.1097/CAD.0000000000000274
Citation Information
Andrew J. Cowan, Shani L. Frayo, Oliver W. Press, Maria C. Palanca-Wessels, et al.. "Bortezomib and fenretinide induce synergistic cytotoxicity in mantle cell lymphoma through apoptosis, cell-cycle dysregulation, and IκBα kinase downregulation." Anti-Cancer Drugs Vol. 26 Iss. 9 (2015) p. 974 - 983
Available at: http://works.bepress.com/john-pagel/76/